Life Science Insights

Third Eye Associates
  • 0.0 (0)
  • Business
  • Updated Monthly

Dan Mazzucco interviews experts in the biotech and medtech industries.

  1. 4d ago

    CRP#9: Why Every Founder Needs an Iron Gut, and Ego Has No Place in the Game, with Nicole Lipkin, Psy.D.

    Nicole Lipkin built a therapy practice with more than 80 clinicians over 17 years, then walked away to build something that could reach families the clinic never could. Her path from a mail-in subscription box to a stealth learning video game, a text service, and finally a mobile app is a case study in letting customer evidence overrule your own plan. In this episode, Dr. Nicole Lipkin joins Dan Mazzucco to talk about the founder journey behind HeyKiddo, a psychologist-designed parenting companion app. They cover the pivots driven by customer discovery and NSF I-Corps work, choosing a beachhead market, the lessons of building a mental health product in a polarized climate, redesigning around AI in an ethical way, and why HeyKiddo deliberately stays on the non-diagnostic side of the FDA line. They also discuss what the Capital Readiness Program taught her about leading with empathy for herself and her company, and why she believes entrepreneurship takes an iron gut and very little ego. This conversation is for founders and early-stage innovators who want to learn how to pivot on evidence, draw smart regulatory boundaries, and build the emotional resilience to keep going when the plan turns out to be wrong. Dr. Nicole Lipkin is a clinical and organizational psychologist, entrepreneur, author, and speaker who has spent her career helping people understand what drives how they think, feel, and lead. She is the founder and CEO of Equilibria Leadership Consulting, an organizational psychology firm that partners with companies on leadership development, executive coaching, and team effectiveness, and the founder and CEO of HeyKiddo, a psychologist-designed parenting companion for caregivers of children from birth to age 12. Before launching these ventures, she founded and exited Equilibria Psychological, a group practice she scaled over 17 years to more than 80 clinicians. Dr. Lipkin is the author of What Keeps Leaders Up at Night and Why in the Workplace and a Forbes contributor. Her work has been featured by NPR, NBC, CBS, Entrepreneur, and The New York Times Magazine. HeyKiddo is part of the 10th cohort of the Capital Readiness Program run by the University City Science Center in Philadelphia, the focus of this season of Life Science Insights.

    CRP#9: Why Every Founder Needs an Iron Gut, and Ego Has No Place in the Game, with Nicole Lipkin, Psy.D.

  2. Sep 18

    CRP#8: Minimum Viable Is Not Minimum Effort: Building a Reimbursable RPM Business, with Adeyemi Oginni, MD, MBA

    Nearly one in two adults in the US has high blood pressure, and three out of four of them don't have it under control. In this episode, Adeyemi (Yemi) Oginni, CEO and Co-founder of PDC Remote Care, joins Dan Mazzucco to talk about closing the data gap in hypertension management. They cover why episodic blood pressure checks fail patients, how PDC's connected devices give clinicians real-time longitudinal data, why nephrologists became the company's core early adopters, and how Medicare's remote patient monitoring reimbursement changes the economics for small practices. This conversation is for life science founders and clinicians who want to build technology that clinicians will actually adopt, not just technology that works in a demo. Adeyemi (Yemi) Oginni is the Chief Executive Officer and Co-founder of PDC Remote Care, a digital health company that helps physicians manage hypertension using connected devices and software. He trained and practiced as a physician in Nigeria before pivoting into management consulting, working across healthcare, energy, and technology, and later spent time at HP before earning his MBA at Duke University's Fuqua School of Business. He founded PDC Remote Care to close the data gap between what happens in the clinic and what happens in patients' everyday lives, and has since engaged with hundreds of clinical practices across the country to expand access to remote patient monitoring for hypertension.

    CRP#8: Minimum Viable Is Not Minimum Effort: Building a Reimbursable RPM Business, with Adeyemi Oginni, MD, MBA

  3. Sep 4

    CRP#7: Building a Diagnostics Company Without Owning a Single Diagnostic, with Nick Malhomme, CEO of Diagnostics Your Way

    Syphilis, once considered nearly eradicated in the US, has risen 700 percent over the last decade. Congenital cases, passed from mother to newborn, are up 800 percent. In this episode, Nick Malhomme, CEO of Diagnostics Your Way, joins Dan Mazzucco to discuss building an end-to-end platform for testing, care, and support around stigmatized infections such as HIV, viral hepatitis, and other STIs. They cover how the remote consultation and at home testing pathway actually works, the mix of a pending patent and first- mover advantage the company is using to hold off competitors, how public health departments and health systems get persuaded to pay for the service, and the practical differences between navigating the US and UK healthcare markets. This conversation is for life science founders and health tech builders who are trying to reach underserved populations without a single novel diagnostic device to patent. Nick Malhomme is the CEO of Diagnostics Your Way, an end-to-end provider of testing, care, and support for stigmatized infections, including HIV, viral hepatitis, and other STIs. He previously served as International Development Director at Preventx, the UK- based sexual health testing company, where he opened Preventx's first US sales headquarters in Greater Philadelphia. Nick holds a BA in Modern Languages and a Master's in International Business, and has spent more than 20 years in healthcare across a number of C-level roles, including CEO of the Behavioral Health Division of Optum International. A UK national who lived in continental Europe for 15 years, he is now based in Philadelphia with his family.

    CRP#7: Building a Diagnostics Company Without Owning a Single Diagnostic, with Nick Malhomme, CEO of Diagnostics Your Way

  4. Aug 21

    CRP#6: One Man, One Underserved Market, Four Companies: An Afternoon with Dick Moberg

    Every hospital ICU has a monitor for the heart and a monitor for the lungs. Until recently, none of them had one built specifically for the brain. In this episode, Dick Moberg, CEO and Founder of Moberg Analytics, joins Dan Mazzucco to talk about building the fourth brain-monitoring product of his 45-year career. They cover why he named three consecutive companies after himself, how a Department of Defense grant let him spin his current company out overnight, why federal funding cuts in 2025 forced a pivot from grants to a $600,000 venture seed round led by Ben Franklin Technology Partners, and how Moberg Analytics is now live in nine paid pilot hospitals across the U.S. and Europe while pursuing FDA 510(k) clearance. This conversation is for medical device founders navigating the shift from grant funding to institutional capital, and for anyone curious what it actually takes to build the same kind of company three times over. Dick Moberg is a serial entrepreneur in the neurological monitoring device field, based in Philadelphia. Over a 45-year career that began with engineering and biomedical graduate work at the University of Pennsylvania, he has developed four generations of brain monitors for surgical and critical care applications, founding Moberg Medical, Moberg ICU Solutions, and now Moberg Analytics. Moberg ICU Solutions grew for roughly 20 years on SBIR and NIH grant funding before being acquired by a European private equity healthcare group. Moberg Analytics, founded six years ago, applies AI and advanced analytics to the multimodal brain-injury data his prior company pioneered collecting, helping clinicians guide acute care for stroke, head injury, and hemorrhage patients. The company began on a $4.5 million Department of Defense grant and has since raised a $600,000 seed round led by Ben Franklin Technology Partners, with a $2 million goal to fund FDA clearance and R&D. Moberg was part of the tenth cohort of the Capital Readiness Program at the University City Science Center in Philadelphia.

    CRP#6: One Man, One Underserved Market, Four Companies: An Afternoon with Dick Moberg

  5. Aug 7

    CRP#5: When Do You Need Regulatory Help, with Shaherah Yancy

    Most early-stage founders know they need regulatory help. What they don't know is that by the time they think they need it, they're already two years behind. The submission is not the strategy — and confusing the two is one of the most expensive mistakes in medtech. In this episode, Shaherah Yancy, founder of Research Lifecycle Solutions, joins Dan Mazzucco to talk about what regulatory strategy actually means for early-stage founders. They discuss the five milestones every medtech company must hit, why regulatory is the anchor to your entire commercialization plan, how FDA has become more collaborative when you bring quality questions, and why the founders who win are playing chess while others are playing checkers. This conversation is for medtech founders and innovators who suspect their regulatory thinking is a checkbox exercise and are ready to find out what it actually should be. Shaherah Yancy is the founder and CEO of Research Lifecycle Solutions (RLS), an internationally recognized clinical scientist, award-winning regulatory strategist, and global keynote speaker. With over 20 years in life sciences, she has led regulatory, clinical, and commercialization strategies behind hundreds of MedTech and BioTech innovations launched across the U.S., Canada, Europe, China, and Australia. Before founding RLS, Shaherah held leadership roles at Medtronic, Smith + Nephew, and Stryker, where she directed global clinical affairs and market access for Class I–III medical devices, robotics, and enabling technologies. She has been named Best Regulatory Consultant by Consulting Magazine and nominated for Best Regulatory Strategy Consultancy of the Year by MedTech World. Theme Music: Prelude, composed andperformed by Benjamin Mazzucco, © 2026. Used with permission.

    CRP#5: When Do You Need Regulatory Help, with Shaherah Yancy

  6. Jul 24

    CRP#4: Show a Child what Success Looks Like: The Science Behind Wide Therapy, with Rinat Hitelman, BCBA, Co-Founder and CEO of Wide Therapy

    Eighty percent of adults on the autism spectrum are unemployed or unable to live independently. We spend more on autism than on diabetes, but most of those individuals still can't cross the finish line on basic life skills. Rinat Hitelman spent 20 years watching that gap from the inside, and then built a company to close it. In this episode, Rinat Hitelman, BCBA and Co-Founder and CEO of Wide Therapy, joins Dan Mazzucco to explore how personalized digital self-simulation helps neurodiverse children master real-world life skills. They discuss the behavioral science behind "changing the prediction," how Wide Therapy navigates the regulatory landscape as a non-device behavioral tool, and the company's B2B model selling to ABA therapy centers, schools, and hospitals. The conversation also covers the unexpected resilience required to build a startup through active conflict in Israel, including how Wide Therapy opened its platform for free to Israeli families after October 7, and what Rinat learned at the Capital Readiness Program about how investors really think. This conversation is for life science founders and entrepreneurs who want to understand how a clinician-turned-founder identified a systemic gap, built a novel solution around behavioral science, and is navigating the commercial path into the U.S. market. Rinat Hitelman is the Co-Founder and CEO of Wide Therapy, a patented digital health platform that enables neurodiverse children and adults to independently practice and master real-world life skills through personalized self-simulation. A Board Certified Behavior Analyst (BCBA) with over 20 years of experience in early intervention and autism therapy, Rinat spent her career working directly with hundreds of families, therapists, and educational teams before founding Wide Therapy. The company works with ABA therapy centers, therapeutic schools, non-profits, and leading hospitals including Children's National Hospital in Washington, D.C. Wide Therapy is headquartered in Israel with a growing U.S. presence and has been recognized as a finalist for Best in Class in the Kids Health Category of the Digital Health Hub Foundation Digital Health Awards. Theme Music: Prelude, composed andperformed by Benjamin Mazzucco, © 2026. Used with permission.

    CRP#4: Show a Child what Success Looks Like: The Science Behind Wide Therapy, with Rinat Hitelman, BCBA, Co-Founder and CEO of Wide Therapy

  7. Jul 10

    CRP#3: 90% of Patients Don't Do Their PT. Band Connect is Fixing That, with co-Founder Abby McInturf

    $380 billion is spent annually on musculoskeletal care in the United States — more than cancer, diabetes, and cardiac care combined. And 90% of patients don't follow their plan of care. Physical therapy has an adherence problem, and the model built around three in-clinic visits per week isn't solving it. In this episode, Abby McInturf, co-founder of Band Connect, joins Dan Mazzucco to talk about building a hybrid physical therapy platform from a class project at the University of Cincinnati. They discuss how customer discovery led to a pivot before the product even existed, why Band Connect put clinical evidence ahead of revenue, how sensor-enabled home equipment lets physical therapists extend care beyond the clinic wall, and why reducing visit frequency actually improves completion rates. They also get into co-founder dynamics, raising a seed round in Ohio, and what it means to problem-solve across every role in a resource-constrained startup. This conversation is for medtech founders and healthcare entrepreneurs who are pre-revenue and wondering whether they have enough to start — and whether the problem they're solving is real enough to bet on. Abby McInturf is the co-founder of Band Connect, a patented hybrid physical therapy platform that augments in-person care with a virtually supervised at-home experience through sensor-enabled exercise equipment. She holds a B.S. in Industrial Design from the University of Cincinnati's DAAP program, where she completed five co-ops with medical and consumer brands and developed a concussion mitigation tool for female soccer athletes before pivoting to physical therapy. Since founding Band Connect, McInturf has led product development, clinical trial preparation, UX design, and go-to-market strategy. Band Connect has completed IRB-approved clinical trials with major health systems and raised a seed round led by Jumpstart Ventures with participation from Techstars.

    CRP#3: 90% of Patients Don't Do Their PT. Band Connect is Fixing That, with co-Founder Abby McInturf

  8. Jun 26

    CRP#2: How a Robot Became a Shoe: Cadense Adaptive Footwear, with Tyler Susko, Ph.D. and Johannes Sauer

    During a feasibility study at MIT, patients walked on a robotic treadmill that removed the floor during the swing phase of gait. The result was simple and striking: people just walked better. One patient said, "I wish I could take it outside the lab." That sentence became a company. In this episode, Cadense co-founders Tyler Susko and Johannes Sauer, join Dan Mazzucco to talk about translating a decade of MIT and UCSB robotics research into a variable-friction adaptive shoe for people with neurological conditions. They discuss the engineering behind passive variable friction technology, navigating FDA registration through customer reviews, securing an NIH R01 grant, the founder duo dynamic and why humility matters more than hustle, and why awareness, not technology, is their biggest challenge with 40,000 pairs sold and 60 million potential customers in the U.S. This conversation is for medtech founders and academic inventors who are sitting on something that helps people and aren't sure how to get it out of the lab. Tyler Susko, Ph.D., is the CTO and founder of Cadense and a professor of teaching at UC Santa Barbara, where he has taught product and machine design for over a decade. He completed his Ph.D. at MIT, where he developed the Skywalker — a robotic gait rehabilitation treadmill — and holds patents on the variable friction technology that became the foundation for Cadense footwear. Johannes Sauer is the CEO and co-founder of Cadense, bringing over a decade of consumer brand and direct-to-consumer e-commerce experience to the company. He holds an MBA from the University of Graz and previously served as CEO for consumer and high-tech brands before joining Cadense in 2022. Together they have built Cadense into a registered medical device company with NIH-funded clinical research underway at the Shirley Ryan AbilityLab, the top-ranked stroke rehabilitation hospital in the U.S. Theme Music: Prelude, composed andperformed by Benjamin Mazzucco, © 2026. Used with permission.

    CRP#2: How a Robot Became a Shoe: Cadense Adaptive Footwear, with Tyler Susko, Ph.D. and Johannes Sauer
See All (30)

About

Dan Mazzucco interviews experts in the biotech and medtech industries.

Information

  • Creator
    Third Eye Associates
  • Years Active
    2025 - 2026
  • Episodes
    30
  • Rating
    Clean
  • Copyright
    © Third Eye Associates
  • Show Website
    Life Science Insights